Team

We are led by globally recognised scientists in the field of age-related disease with more than 1000 scientific publications and an award-winning AI team with more than 30 global AI awards.

MANAGEMENT TEAM

Wade Smith

Wade Smith

CHAIRMAN AND CEO

Bimal Shah

Bimal Shah

COO

Hamish Badenoch

Hamish Badenoch

DIRECTOR & CFO

Paul Sitoh

Paul Sitoh

HEAD OF BLOCKCHAIN TECHNOLOGY

Drug Discovery Advisory Team

Prof. David Rubinstein

Prof. David Rubinstein

Chief Scientific Adviser

Deputy Director, Cambridge Institute of Medical Research

Prof. Jon Storm-Mathisen

Prof. Jon Storm-Mathisen

Adviser, Neurological Research

Senior Professor of Medicine, University of Oslo

Prof. Evandro Fang

Prof. Evandro Fang

Adviser, Early Stage Drug Discovery

Associate Professor, University of Oslo

Prof. Geir Selbæk

Prof. Geir Selbæk

Adviser, Biobank

Research director and professor, Norwegian National Advisory

Disease Diagnosis Advisory Team

Prof. Linda Hildegard Bergersen

Prof. Linda Hildegard Bergersen

Adviser, Aging

Dean of Research, Faculty of Dentistry, University of Oslo

Prof. Hilde Loge Nilsen

Prof. Hilde Loge Nilsen

Adviser, Biological Research

Research director of EpiGen, Akershus University Hospital

Prof. Henrik Schirmer

Prof. Henrik Schirmer

Adviser, Cardiovascular

Professor in cardiovascular epidemiology, University of Oslo

Dr Guang Yang

Dr Guang Yang

Adviser, Medical Imaging

Senior research fellow, Imperial College


ALADDIN HEALTHCARE TECHNOLOGIES SE

BOARD OF DIRECTORS


WADE MENPES-SMITH
CHAIRMAN & MANAGING DIRECTOR

BIMAL SHAH
DEPUTY CHAIRMAN

HAMISH BADENOCH
MEMBER

IMPRINT

Aladdin Healthcare Technologies SE
Unter den Linden 10
10117 Berlin

Berlin MD: Wade Menpes-Smith
Board Chairman: Wade Menpes-Smith
Commercial Register: Berlin, HRB 173762

Seat of the company: Berlin